Cellebrite DI (CLBT) Competitors $16.24 -0.02 (-0.12%) Closing price 04:00 PM EasternExtended Trading$16.35 +0.11 (+0.68%) As of 05:50 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock CLBT vs. MNDY, BSY, PAYC, SNAP, SAIL, YMM, MBLY, TEM, NBIS, and NICEShould you be buying Cellebrite DI stock or one of its competitors? The main competitors of Cellebrite DI include monday.com (MNDY), Bentley Systems (BSY), Paycom Software (PAYC), Snap (SNAP), Sailpoint (SAIL), Full Truck Alliance (YMM), Mobileye Global (MBLY), Tempus AI (TEM), Nebius Group (NBIS), and NICE (NICE). These companies are all part of the "computer software" industry. Cellebrite DI vs. Its Competitors monday.com Bentley Systems Paycom Software Snap Sailpoint Full Truck Alliance Mobileye Global Tempus AI Nebius Group NICE Cellebrite DI (NASDAQ:CLBT) and monday.com (NASDAQ:MNDY) are both computer and technology companies, but which is the superior investment? We will compare the two businesses based on the strength of their analyst recommendations, institutional ownership, profitability, earnings, dividends, risk, valuation and media sentiment. Which has more volatility & risk, CLBT or MNDY? Cellebrite DI has a beta of 1.32, meaning that its stock price is 32% more volatile than the S&P 500. Comparatively, monday.com has a beta of 1.3, meaning that its stock price is 30% more volatile than the S&P 500. Is CLBT or MNDY more profitable? monday.com has a net margin of 5.08% compared to Cellebrite DI's net margin of -46.34%. Cellebrite DI's return on equity of 35.36% beat monday.com's return on equity.Company Net Margins Return on Equity Return on Assets Cellebrite DI-46.34% 35.36% 13.09% monday.com 5.08%7.87%4.79% Which has stronger earnings & valuation, CLBT or MNDY? monday.com has higher revenue and earnings than Cellebrite DI. Cellebrite DI is trading at a lower price-to-earnings ratio than monday.com, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioCellebrite DI$401.20M9.69-$283.01M-$0.96-16.92monday.com$971.99M15.58$32.37M$0.98304.45 Does the media prefer CLBT or MNDY? In the previous week, monday.com had 7 more articles in the media than Cellebrite DI. MarketBeat recorded 12 mentions for monday.com and 5 mentions for Cellebrite DI. monday.com's average media sentiment score of 1.10 beat Cellebrite DI's score of 0.41 indicating that monday.com is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Cellebrite DI 1 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral monday.com 7 Very Positive mention(s) 1 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Do analysts recommend CLBT or MNDY? Cellebrite DI currently has a consensus target price of $22.43, suggesting a potential upside of 38.11%. monday.com has a consensus target price of $347.09, suggesting a potential upside of 16.33%. Given Cellebrite DI's stronger consensus rating and higher probable upside, equities research analysts plainly believe Cellebrite DI is more favorable than monday.com.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Cellebrite DI 0 Sell rating(s) 0 Hold rating(s) 7 Buy rating(s) 0 Strong Buy rating(s) 3.00monday.com 0 Sell rating(s) 4 Hold rating(s) 21 Buy rating(s) 0 Strong Buy rating(s) 2.84 Do insiders & institutionals hold more shares of CLBT or MNDY? 45.9% of Cellebrite DI shares are owned by institutional investors. Comparatively, 73.7% of monday.com shares are owned by institutional investors. 5.7% of Cellebrite DI shares are owned by company insiders. Comparatively, 22.3% of monday.com shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth. Summarymonday.com beats Cellebrite DI on 11 of the 16 factors compared between the two stocks. Get Cellebrite DI News Delivered to You Automatically Sign up to receive the latest news and ratings for CLBT and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding CLBT and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart CLBT vs. The Competition Export to ExcelMetricCellebrite DIINTERNET SOFTWARE IndustryComputer SectorNASDAQ ExchangeMarket Cap$3.89B$17.98B$27.12B$8.73BDividend YieldN/A2.59%2.93%4.21%P/E Ratio-16.9265.4635.3619.34Price / Sales9.69124.762,457.24112.13Price / Cash44.5291.9737.4756.46Price / Book9.968.296.845.50Net Income-$283.01M$334.48M$776.75M$248.18M7 Day Performance4.10%0.61%1.13%0.76%1 Month Performance-5.64%0.54%4.50%4.44%1 Year Performance37.74%56.86%52,207.93%16.92% Cellebrite DI Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)CLBTCellebrite DI3.4148 of 5 stars$16.24-0.1%$22.43+38.1%+39.2%$3.89B$401.20M-16.921,167Positive NewsMNDYmonday.com3.2269 of 5 stars$289.53+3.4%$347.86+20.1%+35.5%$14.70B$1.04B482.551,060Positive NewsBSYBentley Systems3.822 of 5 stars$50.02+1.4%$52.00+4.0%+4.3%$14.60B$1.39B45.065,000Analyst UpgradeInsider TradePAYCPaycom Software4.3774 of 5 stars$246.24+0.5%$226.90-7.9%+62.3%$14.25B$1.91B27.677,306Positive NewsSNAPSnap3.306 of 5 stars$8.27+4.1%$35.62+330.8%-46.8%$13.82B$5.53B-19.695,290Positive NewsSAILSailpointN/A$23.40+3.5%$26.50+13.2%N/A$13.02B$495.41M0.002,645YMMFull Truck Alliance3.2441 of 5 stars$12.13+1.2%$15.00+23.6%+44.7%$12.69B$11.67B28.897,100Positive NewsMBLYMobileye Global1.8625 of 5 stars$15.43+1.2%$18.63+20.7%-32.8%$12.53B$1.85B-4.043,700News CoveragePositive NewsOptions VolumeTEMTempus AI1.7357 of 5 stars$72.00+1.0%$63.42-11.9%+169.8%$12.46B$803.32M-9.232,300Trending NewsAnalyst ForecastNBISNebius Group3.1721 of 5 stars$50.46+7.1%$66.50+31.8%N/A$11.90B$161.40M-88.5326,361Gap UpNICENICE4.1774 of 5 stars$167.64+1.2%$208.92+24.6%+1.8%$10.60B$2.78B24.807,100Trending NewsAnalyst Revision Related Companies and Tools Related Companies monday.com Alternatives Bentley Systems Alternatives Paycom Software Alternatives Snap Alternatives Sailpoint Alternatives Full Truck Alliance Alternatives Mobileye Global Alternatives Tempus AI Alternatives Nebius Group Alternatives NICE Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:CLBT) was last updated on 6/25/2025 by MarketBeat.com Staff From Our PartnersElon’s BIGGEST warning yet?Tesla's About to Prove Everyone Wrong... Again Back in 2018, when Jeff Brown told everyone to buy Tesla… ...Brownstone Research | Sponsored3..2..1.. AI 2.0 ignition (don’t sleep on this)I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredSilicon Valley Gold RushA new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredTrump’s true trade war strategyThe media and financial pundits are all misreading Trump’s actions. They think Trump wants to make Canada t...Porter & Company | SponsoredCrypto Is Pumping Again – Now Comes the Real OpportunityThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cellebrite DI Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share Cellebrite DI With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy CLBT Stock Free CLBT Stock Alerts